Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
-Medical News
 Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory

 

 

 
Hematologist/Researcher Elected to Institute of Medicine
 

Katherine A. High, MD, has been elected as one of 65 new members of the Institute of Medicine (IOM), which recognizes individuals who have contributed to the advancement of healthcare, the medical sciences and public health.

High is the director of the Center for Cellular and Molecular Therapeutics at The Children’s Hospital of Philadelphia and the William H. Bennett Professor pf Pediatrics at the University of Pennsylvania School of Medicine. She is a Howard Hughes Medical Institute investigator and leads a laboratory funded by the National Institutes of Health. A leading researcher in hematology and gene therapy, High’s studies of the molecular biology of hemophilia led to clinical trials of gene therapy to treat the bleeding disorder at The Children’s Hospital of Philadelphia. She is known internationally for her research on factor IX gene therapy. Her work has been published in such highly respected journals as Haemophilia, Nature and Blood. High is a former president of the American Society of Gene Therapy.

High has been at The Children’s Hospital in Philadelphia since 1992. Prior to that she directed the Clinical Coagulation Laboratory at the University of North Carolina Hospitals. High is a former member of the National Hemophilia Foundation’s Medical and Scientific Advisory Council. She has also served as chair of NHF’s Research Review Committee and a member of NHF’s Gene Therapy Working Group.

“It is a great pleasure to welcome these distinguished and influential individuals to the Institute of Medicine,” said Harvey V. Fineberg, IOM President. “Members are elected through a highly selective process that recognizes people who have made major contributions to the advancement of the medical sciences, healthcare and public health. Election is considered one on the highest honors in the fields of medicine and health.”

The IOM was founded in 1970 by the National Academy of Sciences as an independent, nongovernmental resource for scientifically informed analysis and recommendations on a variety of human health issues. IOM’s committees, which are composed of volunteers who are experts in various fields of medicine and health, engage in a broad range of studies on health policy issues. With the addition of the new members, IOM’s total membership is now 1,692.

Source: IOM press release dated October 8, 2007; PRNewswire October 10, 2007

 

This section of our Web site is sponsored by: